Bacterial infections Trials in Durham, United States

Bacterial infections has been the subject of sustained clinical investigation across multiple research sites.

10 total trials for this combination

Trials

NCT ID	Title	Status	Phase
NCT02527681	Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics	TERMINATED	PHASE1
NCT01946568	A Single Dose Study To Investigate The Pharmacokinetics and Safety Of Dalbavancin In Hospitalized Children Aged 3 Months to 11 Years.	COMPLETED	PHASE1
NCT02814916	Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA	COMPLETED	PHASE3
NCT03192072	A Rapid Test for Acute Respiratory Illness	COMPLETED	—
NCT00488345	Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age	COMPLETED	PHASE2
NCT03617042	Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection	RECRUITING	PHASE1
NCT02688790	Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection	TERMINATED	PHASE1
NCT00000811	A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children	COMPLETED	PHASE2
NCT03696550	A Safety and PK Study of IV Eravacycline	COMPLETED	PHASE1
NCT03646227	Multi-Drug Resistant Organism Network	COMPLETED	—